6533b7d8fe1ef96bd126aba8

RESEARCH PRODUCT

KDM5B and CBX5 as potential tumor-associated immunogenic antigens in triple-negative breast cancer (TNBC)

Annette HasenburgL IstengirA RothermelWalburgis BrennerAnne-sophie HeimesMartina Schmidt

subject

Antigenbusiness.industryCancer researchMedicinebusinessTriple-negative breast cancerhttps://doi.org/10.1055/s-0041-1730174